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Abstract
DNA repair is essential for cell viability and proliferation. In addition to reactive oxygen produced
as a byproduct of their own metabolism, intracellular parasites also have to manage oxidative
stress generated as a defense mechanism by the host. The spontaneous loss of DNA bases due to
hydrolysis and oxidative DNA damage in intracellular parasites is great, but little is known about
the type of DNA repair machineries that exist in these early-branching eukaryotes. However, it is
clear processes similar to DNA base excision repair (BER) must exist to rectify spontaneous and
host-mediated damage in Toxoplasma gondii. Here we report that Toxoplasma gondii, an
opportunistic protozoan pathogen, possesses two apurinic/apyrimidinic (AP) endonucleases that
function in DNA BER. We characterize the enzymatic activities of Toxoplasma exonuclease III
(ExoIII, or Ape1) and endonuclease IV (EndoIV, or Apn1), designated TgAPE and TgAPN,
respectively. Over-expression of TgAPN in Toxoplasma conferred protection from DNA damage,
and viable knockouts of TgAPN were not obtainable. We generated an inducible TgAPN
knockdown mutant using a ligand-controlled destabilization domain to establish that TgAPN is
critical for Toxoplasma to recover from DNA damage. The importance of TgAPN and the fact that
humans lack any observable APN family activity highlights TgAPN as a promising candidate for
drug development to treat toxoplasmosis.
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1. Introduction
The Base Excision Repair (BER) pathway is responsible for the repair of oxidative and
alkylation DNA damage, resulting in protection against the deleterious effects of
endogenous and exogenous agents encountered on a daily basis. It is the major DNA repair
pathway that remedies oxidative DNA damage with little backup or alternative pathways
[1]. Removal of the incorrect or damaged base by a DNA glycosylase comprises the first
step of the BER pathway. The second step is mediated by an apurinic/apyrimidinic (AP)
endonuclease, which hydrolyzes the phosphodiester backbone immediately 5′ to an AP site.
This incision generates a normal 3′-hydroxyl group and an abasic deoxyribose-5-phosphate,
which is processed by DNA polymerase β and ligase.
AP sites can arise spontaneously or be generated following exogenous treatment of cells by
oxidative and alkylating agents as well as ionizing radiation [2–3]. If not repaired by AP
endonucleases in dividing cells, AP sites have dramatic consequences as they can lead to
single and subsequently double DNA strand breaks, which are lethal to the cell [4]. Bacteria,
yeast, or human cells lacking AP endonuclease repair activity are hypersensitive to agents
(e.g. alkylating or oxidizing) that induce the formation of AP sites [2]. Similar observations
have been documented for the kinetoplastid protozoan, Leishmania major; in this case, over-
expression of its AP endonuclease conferred protection against various agents known to
induce DNA damage [5].
Class II endonucleases are specific for AP sites and lack DNA glycosylase activity. There
are two families of class II AP endonucleases based on homology to the E. coli enzymes that
are structurally unrelated and differ in their requirement for Mg2+. Exonuclease III (ExoIII)
is Mg2+-dependent and exhibits a four-layered α/β-sandwich fold [6–7] while endonuclease
IV (EndoIV) is Mg2+-independent and has a α8/β8 TIM-barrel fold [8–9] including three
tightly bound Zn2+ ions. Human Ape1 shares sequence homology with E. coli ExoIII and,
like ExoIII in E. coli, serves as the predominant AP endonuclease in humans [10–11]. There
is no evidence of an EndoIV AP endonuclease in mammals. In the yeast Saccharomyces
cerevisiae, the primary AP endonuclease is an EndoIV homologue called APN1 [12]. The
importance of EndoIV AP endonucleases on cell viability has been explored in some
species. S. cerevisiae lacking APN1 are viable but hypersensitive to both oxidative and
alkylating agents that damage DNA [13]. Knockdown of APN1 in Caenorhabditis elegans
diminishes genomic stability, increases sensitivity to DNA damaging agents, and causes
defective development [14]. In general, however, APN1 AP endonucleases have not been
thoroughly characterized.
In addition to generating reactive oxygen species (ROS) during metabolism, intracellular
protozoan parasites are also exposed to oxidative stress produced by immune effector cells
[15]. It has been established that such parasites are highly sensitive to ROS [16]. We
hypothesized that AP endonucleases in the obligate intracellular parasite Toxoplasma gondii
(phylum Apicomplexa) would be critical for viability by protecting against DNA damage
and particularly in the context of host immune insults on the parasite. Toxoplasma causes
congenital birth defects and serious opportunistic disease in immunocompromised
individuals, and is a relative of the malaria parasite Plasmodium. Current treatments to
control acute toxoplasmosis caused by the proliferative tachyzoite stage are inadequate as
these drugs have serious toxic side effects. Thus, an urgent need exists to identify new drug
targets that may be exploited in the development of safer therapies. In this study we
establish that apicomplexan parasites have both APE1 and APN1 homologues (TgAPE and
TgAPN, respectively). We present multiple lines of evidence that identify TgAPN as an
abundant and critical AP endonuclease in Toxoplasma tachyzoites. Through regulated
Onyango et al. Page 2
DNA Repair (Amst). Author manuscript; available in PMC 2012 May 5.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
knockdown of the TgAPN protein, we also establish that this DNA repair enzyme is
required for recovery from DNA damage.
2. Materials and methods
2.1. Parasite culture and growth assays
Toxoplasma gondii tachyzoites were cultured in human foreskin fibroblasts (HFF) in
Dulbecco Modified Eagle’s Media (Invitrogen) supplemented with 1% heat inactivated fetal
bovine serum at 37°C and 5% CO2. For plaque assays, 1000 parasites were inoculated into
confluent HFF monolayers in 24-well plates and allowed to grow undisturbed for 7 days at
37°C. Infected monolayers were fixed in cold 100% methanol for 10 min prior to staining
and counting. All plaque assays were performed in triplicate. For B1 assays, genomic DNA
was collected at various time points from infected HFFs using the DNeasy kit (Qiagen) and
analyzed as described [17]. Parasite doubling assays were performed in T-25 cm2 flasks
containing confluent HFF monolayers. 107 parasites inoculated into the flask and 50 random
vacuoles were counted at each of the indicated time points.
2.2. Chemicals
Methyl methanesulfonate (MMS) was obtained from Sigma (M4016) in DMSO at a
concentration of 11.8 M (1.3 g/ml) and stored at 4 °C. Shield-1 (CheminPharma, New
Haven, catalog # CIP-S1) was dissolved in 100% ethanol at a concentration of 0.5 mM and
stored at −20 °C. 200 nM Shield-1 was added to designated parasite cultures to stabilize the
indicated fusion protein.
2.3. Cloning of TgAPE and TgAPN
The TgAPE and TgAPN open reading frames were amplified from an RH strain tachyzoite
cDNA library using primers designed to the predicted gene at the Toxoplasma genomics
resource (ToxoDB, www.toxodb.org). 5′- and 3′-rapid amplification of cDNA ends (RACE)
was performed with the GeneRacer kit (Invitrogen) using tachyzoite mRNA as a template
for reverse transcription (RT) with the provided random primers or oligo dT primer. RT-
PCRs were performed using the SuperScript™ One-Step RT-PCR kit from Invitrogen
following manufacturer’s instructions.
2.4. Generation of parasites over-expressing TgAPE and TgAPN
FLAG-tagged TgAPE and TgAPN were ligated into the ptubFLAG::HX expression vector
using the NdeI and AvrII restriction sites [18]. FLAGAPN was amplified using primers
(sense) 5′-
TCGATCGCATATGAAAATGGACTACAAGGACGACGACGACAAGACGGCTGCAGCG
TCCCTAAGAAAAACCAAGG and (antisense) 5′-
TCGATCGCCTAGGTCACTCTTCGATGATGAATTTGTACATCATCTCC, where the
underscored sequences represent the NdeI and AvrII restriction sites, respectively, and
FLAG sequence is italicized. FLAGAPE was amplified using primers (sense) 5′-
ATCATATGAAAATGGACTACAAGGACGACGACGACAAGTCTGTTCACAGAGCAGT
GAACTCA and (antisense) 5′-
ATCGAACCTAGGTCAACTGGAGGCCTGGACGTTTCGCG. The N-terminal FLAG-
tagged TgAPE and TgAPN constructs were linearized with NotI and electroporated into RH
strain tachyzoites lacking hypoxanthine-xanthine-guanine phosphoribosyltransferase
(RHΔHX) [19]. Transgenic parasites were selected in mycophenolic acid (25μg/ml) and
xanthine (50μg/ml) and cloned by limited dilution.
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2.5. Generation of parasites with regulatable TgAPN protein
We tagged the 3′ end of the endogenous TgAPN genomic locus with two hemagglutin (HA)
epitopes and destabilization domain (DD). 1504 bp of the 3′ end of the TgAPN genomic
locus was amplified minus the stop codon using Phusion® High-Fidelity DNA Polymerase
(New England Biolabs) and the following primers: (sense) 5′-
TACTTCCAATCCAATTTAATGCCCTCCACAGTGTACAGACAGTTCCTCTAGGC
and (antisense) 5′-
TCCTCCACTTCCAATTTTAGCCTCTTCGATGAATTTGTACATCATCTCCG. The
amplified product was cloned into the LIC-HA2X-DD-DHFR-TS vector as described [20].
The completed plasmid was linearized with BlpI and transfected into ΔKu80 RH strain
parasites; pyrimethamine resistant clones were examined for the loss of TgAPN-DD protein
in the absence of Shield-1.
2.6. Purification of recombinant TgApe and TgApn
An expression vector for TgAPE was constructed in pET28a including an N-terminal
cleavable hexa-histidine tag using NdeI and NotI restriction sites and verified by DNA
sequencing. Following transformation into the Rosetta E. coli strain, a 1 liter culture was
induced at 37 °C for 4 hrs, after which cells were pelleted and stored at −80 °C prior to
purification. The cell pellet was resuspended in 25 ml of Lysis buffer, Buffer A (50 mM Na
phosphate pH 7.8, 0.3M NaCl) with 10 mM imidazole, sonicated, and centrifuged at 35K for
35 min in an ultracentrifuge. The crude extract was incubated with 1 ml of a Ni-NTA
agarose slurry for 45 minutes at 4 °C, placed in a column, washed with 10 ml of wash Buffer
A with 20 mM imidazole and eluted with 2 × 1.5 ml of elution buffer, Buffer A with 250
mM imidazole. Fractions were diluted to 0.05M NaCl with Buffer B (50 mM HEPES pH
7.5, 1 mM DTT) and applied to a Q-Sepharose column using an AKTA FPLC system. The
protein was then eluted from the Q-Sepharose column using a NaCl gradient (0.05M NaCl
to 1M NaCl). The fractions containing TgAPE were combined and digested overnight with
thrombin in order to remove the N-terminal hexa-His affinity tag. The sample was then
diluted to a final salt concentration of 0.05M NaCl with Buffer B and subjected to a NaCl
gradient separation on the Q-Sepharose column as before. Fractions including TgAPE were
combined, concentrated, and stored at −80 °C. The purified sample is greater than 95% pure
as judged by SDS-PAGE analysis
An expression vector for TgAPN was constructed in pET15b using NdeI and BamHI
restriction sites and verified by DNA sequencing. Expression and purification were similar
to that described for TgAPE with the same buffers used for Ni-NTA affinity purification
followed by S-Sepharose ion-exchange chromatography. The fractions containing TgAPN
from the Ni-NTA purification were pooled, diluted in 50 mM HEPES pH 7.0, 1 mM DTT,
and eluted using a NaCl gradient 0.05–1 M in the same buffer. The fractions containing
TgAPN were combined and digested overnight with thrombin in order to remove the N-
terminal hexa-His affinity tag. The sample was then diluted to a final salt concentration of
0.05M NaCl with Buffer B and subjected to a NaCl gradient separation on the S-Sepharose
column as before. Fractions including TgAPN were combined, concentrated, and stored at
−80 °C. The purified sample is approximately 95% pure.
2.7. Generation of antisera recognizing TgApe and TgApn
Purified recombinant TgApe and TgApn (with N-terminal poly-His tag removed) were
injected into rabbits for production of polyclonal antisera at Quality Controlled
Biochemicals (Hopkinton, MA). Raw antiserum was affinity-purified over antigen-based
columns. Recombinant TgApe was immobilized on Affi-Gel-15 and TgApn was
immobilized on Affi-Gel-10 (Bio-Rad), and the respective antisera were concentrated using
Amicon centrifugal columns.
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2.8. Immunofluorescence assays
HFFs grown in 12-well plates containing glass coverslips were infected with parasites. 24
hrs post-infection the cultures were fixed with 3% paraformaldehyde for 15 min at room
temperature. The infected cells were permeabilized with 0.2% Triton X-100 in PBS for 10
min and blocked in 3% BSA (fraction V, OmniPur) in PBS for 30 min. Primary antibodies
used included affinity-purified polyclonal TgAPN 1:10,000 and TgAPE 1:1,000,
monoclonal anti-FLAG antibody 1:5,000 (Sigma F1804). DNA intercalator 4′,6-
diamidino-2-phenylindole (DAPI, Molecular Probes) was applied at a concentration of 0.3
μM for 5 min as a co-stain to visualize nuclei. Coverslips were prepared for viewing using
mounting media with 50% glycerol containing 48μg/ml Mowiol (Calbiochem) and 10μg/ml
DABCO (Sigma) to reduce photobleaching. The slides were analyzed using a Leica DMLB
fluorescent microscope at 100X with a HCX Plan Apo oil immersion objective. Images were
captured with a monochrome SPOT-RTSE camera and Spot Advance software (version 4.6).
2.9. Immunoblotting
Affinity-purified antisera recognizing TgApe and TgApn were diluted in Tris-buffered
saline tween (TBST) to a final concentration of 1:10,000. The nitrocellulose membranes
were blocked in 3% BSA for 2 hrs prior to being probed with the respective antibodies.
Donkey anti-rabbit conjugated to horseradish peroxidase diluted 1:5,000 was used as a
secondary antibody (GE Health Care). The signal was detected using an ECL
chemiluminescent system (Thermo Scientific).
2.10. DNA repair assays
AP endonuclease activity for recombinant proteins was measured in a fluorescent-based
kinetic assay using a duplex DNA substrate containing a tetrahydrofuran abasic site mimic
as the substrate. The assay employs fluorescein and dabcyl as a fluor-quench pair in the
following oligonucleotides (5′-6-FAM- GCC GAC FGA GGA CGT ACG CG -3′ and 5′-
CGC GTA CGT CCT CTG TCG GC -Q-3′) from Eurogentec Ltd (San Diego, CA) [21],
where FAM indicates fluorescein and Q, Dabcyl. The oligonucleotides were diluted in water
to a final concentration of 100 μM and annealed in a 4:5 ratio of fluorescein vs. Dabcyl
labeled oligonucleotides. Release of the fluorescein labeled oligonucleotide following
cleavage at the abasic site by an AP endonuclease is achieved by thermal denaturation at
37°C and followed in the kinetic mode on a Tecan Ultra 384 instrument using an excitation
wavelength of 485 nm and emission of 535 nm. TgAPN was assayed in 50 mM MOPS 7.5,
50 mM NaCl, and 0.8% DMSO. An optimal concentration of 4 nM TgAPN was determined
by varying the enzyme concentration with fixed substrate concentration of 25 nM. The
substrate was then varied from 0 to 75 nM to determine Vmax and Km values for this
enzyme. Similarly, 0.05 nM TgAPE was used with substrate concentrations of 0 to 75 nM in
50 mM MOPS 7.5, 50 mM NaCl, 1 mM MgCl2, and 0.8% DMSO. DMSO was included in
the assay in preparation for screening of small molecule inhibitors dissolved in 0.8% DMSO
and found not to affect the activity of the enzyme. Kinetic parameters were calculated from
the average of quadruplicate measurements for each substrate concentration using the
Enzyme Kinetics module in SigmaPlot (SigmaPlot 11.2).
Similar assays were used to measure AP endonuclease activities from wild-type parasite
lysate. Wild-type RH strain Toxoplasma tachyzoites were filter-purified and washed
extensively in PBS to exclude host cell material. No detectable levels of human APE1 were
observed by immunoblot of the purified parasite lysate, even after a 15 min overexposure
(data not shown). To measure total AP endonuclease activity, a master mix was made with
buffer (50 mM HEPES, 1 mM MgCl2, 50 mM KCl and 2 mM DTT), 25 nM final HEX-
labeled oligo and aliquoted in 15 μL increments. To measure TgAPN activity, a buffer
without MgCl2 containing 10 mM final EDTA was used. 100, 250, 500, 1000, 1500 or 3000
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ng parasite lysate in a volume of 5.0 μL was added to each aliquot of master mix and
incubated in a 37 °C water bath. Ten nM recombinant human APE1 or recombinant TgAPN,
along with a sample run with the master mix alone, were run as positive and negative
controls for each assay, respectively. After 30 min incubation, 10 μL of formamide was
added to stop the reaction. The samples were then electrophoresed in a 20% denaturing (7 M
urea) polyacrylamide gel in 1X Tris-borate EDTA at 300 V for 40 min. The resulting bands
were detected and quantified using the FMBioII fluorescence imaging system and software
(Hitachi Genetic Systems, South San Francisco, CA). Each assay was repeated two times.
3. Results
3.1. Apicomplexan parasites have ExoIII and EndoIV AP endonucleases
A search of the Toxoplasma genome web site (ToxoDB.org) revealed that accession number
TGGT1_098640/35.m00892 (chromosome XI) is a homologue of human APE1 (hAPE1,
ExoIII class) and TGGT1_034710/80.m00015 (chromosome IX) a homologue of yeast
APN1 (EndoIV class). We subsequently cloned the full-length cDNA and confirmed the
sequences for each (GenBank accession numbers are HM593513 for TgAPE and
HM593514 for TgAPN). 5′- and 3′-RACE (rapid amplification of cDNA ends) were
performed, revealing that TgAPE has a 5′UTR (untranslated region) of 582 nt and 3′UTR of
320 nt; TgAPN has a 5′UTR of 254 nt and 3′UTR of 424 nt.
BLASTp searches with the deduced amino acid sequence for TgAPE reveal most significant
matches to other apicomplexan APE1 homologues, followed by plant species (rice,
sorghum, and Arabidopsis), which are ~35% identical and ~50% similar. In contrast, TgAPE
is less similar to hAPE1. TgApe is comprised of 513 amino acids while hApe1 only has 318
residues; TgAPE contains 10 insertions and one deletion as compared to the human
sequence, which may have important structural consequences. A PSI-BLAST alignment of
TgAPE to hAPE1 sequences is shown in Supplemental Figure 1. Most but not all of the
residues thought to play an important role in the repair active site are conserved in TgAPE,
including E96, Y171, N174, D210, N212, D282, and H309 (numbering refers to the human
sequence). Notably, three residues that are not conserved are W280 and F266, which form
the walls of the abasic deoxyribose binding site, and R177, which fills the position of the
missing base in the duplex. These residues in TgAPE are M379, S361, and A253,
respectively. The fact that some of the residues in the active site are not conserved suggests
there may be important structural differences in the repair active site.
BLASTp searches with the deduced 472 amino acid sequence of TgAPN reveal that the
most significant matches are to other apicomplexan APN1 homologues, followed by fungal
species (e.g. Chaetomium globosum, Fusarium graminearum, Neurospora crassa,
Cryptococcus neoformans) which are ~40–50% identical and ~60–70% similar. Residues
187 to 463 of TgAPN are 43% identical to E. coli EndoIV, which includes 285 residues
(Supplemental Figure 2). Residues involved in coordinating the three metal ions in the
active site of E. coli EndoIV are conserved in TgAPN. These residues include H255, H295,
and E331 (numbering for TgAPN), which coordinate Zn1, E448, H392, and D365, Zn2, and
D415, H417, and H368, Zn3. In addition, recognition loop residues, R222 and Y258 [22] are
also conserved suggesting that mechanistically TgAPN is very similar to E. coli EndoIV. In
contrast to the APE family enzymes in which the larger TgAPE has a number of sequence
inserts throughout the enzyme that contribute to its significantly larger mass, the difference
in size between TgAPN and E. coli endonuclease IV results primarily from an N-terminal
insertion in TgAPN.
Previous studies and comparative genomics reveal additional insight into the AP
endonucleases in Apicomplexa. Biochemical evidence suggested that Plasmodium
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falciparum (malaria) contains both Mg2+-dependent (APE1) and Mg2+-independent (APN1)
AP endonuclease activities [23]; we have verified that the Plasmodium genome sequence
harbors genes for both APE1 (chr3.glimmerm_170) and APN1 (chr13.genefinder_182r)
homologues. Survey of the Cryptosporidium genome also reveals both APE1
(CpIOWA_EAK87392) and APN1 (CpIOWA_EAK88592) homologues. Phylogenetic
analysis shows that apicomplexan APN1 homologues form a clade with yeast APN1, while
apicomplexan APE1 homologues are more closely related to those found in plants rather
than mammals (Supplemental Figure 3).
3.2. TgAPE and TgAPN AP DNA repair activities
We expressed recombinant TgAPE and TgAPN in E. coli and purified the proteins for
enzymatic analysis. The DNA repair assay utilizes a 5′-hexachloro-fluorescein
phosphoramidite (HEX)-labeled terahydrofuranyl (THF) oligo (the 26 bp oligonucleotide
substrate contains a single THF residue in the middle, yielding a HEX-labeled 13mer
fragment upon incision). THF is a stable synthetic abasic site [24]. The reaction products are
visualized after resolving on 20% polyacrylamide gels. As predicted from their structural
similarities to hAPE1 and yeast APN1, the TgAPE enzyme should require Mg2+ while
TgAPN should be Mg2+-independent. As shown in Figure 1A, TgAPE is capable of
cleaving the THF oligo as evidenced by the accumulation of the lower 13 bp product with
increasing concentrations of enzyme and is only active in the Mg2+-containing buffer.
TgAPN has similar AP endonuclease activity and is active in the presence or absence of
Mg2+ (Figure 1B). Further steady state enzymatic characterizations of TgAPN and TgAPE
were performed using a fluorescent-based solution assay as described in the Materials and
Methods. The THF-containing oligonucleotide substrate concentration was varied from 0 to
75 nM, and Michaelis-Menton Km values of 26.2 and 21.1 nM and Vmax values of 1458 and
110,070 RFU/μg/s, respectively for TgAPN vs. TgAPE, were calculated (Figure 1C, D),
where RFU is a relative fluorescent unit. Thus, while the Km values of each enzyme for the
substrate are similar, the maximum velocity is approximately 75 times faster for TgAPE.
3.3. Size and localization of Toxoplasma AP endonucleases
Polyclonal antisera were generated in rabbits using the recombinant TgAPE and TgAPN
purified from bacteria as antigen. Polyhistidine tags were removed by proteolytic cleavage
prior to immunization. Antibodies were affinity-purified and used to probe Western blots
containing lysates from Toxoplasma tachyzoites or the recombinant protein as control (Fig.
2A). Recombinant TgAPE migrates at the expected MW of 57 kD, but also appears at 52
kD, possibly a breakdown or proteolytic product. Native TgAPE expressed in Toxoplasma
also migrates as two proteins as seen when produced in E. coli, making it likely that this is
protein processing rather than an alternatively spliced product. Native TgAPN migrates
slightly higher than the expected 51 kD in Toxoplasma lysate, possibly due to a post-
translational modification(s).
The antibodies were used in immunofluorescence assays (IFA) to localize the native protein
in Toxoplasma tachyzoites growing inside their host cells. Native TgAPE is present in the
parasite nucleus and cytoplasm while native TgAPN is nuclear (Fig. 2B). Arrowheads in
Fig. 2B point to potential TgAPE present in the apicoplast, a specialized organelle housing a
35 kb extrachromosomal element. We also expressed recombinant FLAG-tagged versions of
TgAPE or TgAPN (tagged at N-terminus) in RH strain tachyzoites (FLAGAPE
or FLAGAPN). Expression of each ectopic copy was driven by the same strong tubulin
promoter as previously described [18]. Following selection and cloning, we performed IFA
to determine the subcellular localization of each tagged Toxoplasma AP endonuclease.
When anti-APE or anti-APN antibodies are used in IFAs of the parasites over-expressing
FLAG-tagged TgAPE or TgAPN, the staining pattern is identical to that seen for wild-type
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parasites (compare Fig. 3, green to Fig. 2B). Moreover, anti-FLAG IFAs of parasites
expressing FLAGAPN confirm nuclear localization of this protein (Fig. 3, red). In contrast to
IFAs with anti-APE, anti-FLAG IFAs of parasites expressing FLAGAPE show almost
exclusive localization to the nucleus (Fig. 3, red). This suggests that the cytosolic staining
for native TgAPE is due to the fact that anti-APE recognizes both full-length and truncated
forms (see Fig. 2A, Western blot). In other words, full-length TgAPE is nuclear, but the
shorter TgAPE (which anti-FLAG would not recognize) is cytoplasmic.
3.4. TgAPN is more abundant than TgAPE in tachyzoites
In other species possessing more than one AP endonuclease, one enzyme is predominant for
BER [25–26]. We therefore sought to establish which AP endonuclease was predominant in
Toxoplasma tachyzoites. An analysis of the expressed sequence tags (ESTs) data at the
ToxoDB Release 6.0 (www.toxodb.org) shows that only 2 ESTs represent TgAPE whereas
>30 ESTs were identified for TgAPN, indicating that TgAPE message levels are very low
compared to those encoding TgAPN. Analysis at the protein level also suggests that TgAPN
is the more prevalent AP endonuclease (Fig. 2A). Proteomics data at the ToxoDB mirrors
our data and what we observed for ESTs in that a large number of peptides in various
independent datasets suggest TgAPN is present in abundance at the protein level; in
contrast, only 2 peptides have been reported matching to TgAPE. Considered together, these
multiple lines of evidence indicate that TgAPN is more predominant than TgAPE at both the
RNA and protein levels in tachyzoites.
We measured total AP endonuclease activity levels in wild-type Toxoplasma lysate using
the AP endonuclease gel assay (Fig. 2C). The percent activity was expressed as a percent of
the value of the cleaved oligo to the total value of the cleaved and uncleaved oligo [24].
TgAPN (Mg2+-independent) activity levels were measured by using Mg2+-free buffer
containing EDTA (Fig. 2D). In both cases, a dose-dependent increase of activity was seen
with increasing amounts of parasite lysate present in the reaction. The results demonstrate
that TgAPN contributes substantially (~50%) to the total amount of AP endonuclease
activity detected in parasite lysate.
3.5. Parasites over-expressing TgAPN are protected from DNA damage
We examined if our transgenic parasites over-expressing recombinant forms of each AP
endonuclease under control of the same heterologous promoter (tubulin) exhibited
cytoprotection against the alkylating agent methyl methanesulfonate (MMS), a well-
established DNA-damaging agent used to study of BER. MMS was chosen to induce DNA
damage rather than H2O2 since Toxoplasma possesses peroxidases and a highly active
catalase [27]. Using three independent growth assays, we determined that Toxoplasma
tachyzoites exposed to MMS have increased viability only when TgAPN is stably over-
expressed; no protection is conferred when TgAPE is over-expressed (Fig. 4). Figure 4A is a
PCR-based assay for the parasite B1 gene that monitors growth over 5 days following
exposure to an insult of 400 μM MMS for 2 hrs. A plaque assay performed at day 7
following 400 or 800 μM MMS produced similar results (Fig. 4B). Finally, a Toxoplasma
doubling assay performed on parasites over a time course following exposure to 800 μM
MMS verified that those over-expressing TgAPN were remarkably refractory to this insult
(Fig. 4C). It should be noted that the growth rates of each over-expressing line are virtually
identical to each other as well as wild-type under vehicle-treated conditions (Fig. 4). We
also examined the relative levels of ectopic FLAGAPN and FLAGAPE; while driven by the
same promoter, it is possible that a higher copy number could explain the protection seen in
TgAPN over-expressers. However, immunoblots demonstrated that there is more FLAGAPE
compared to FLAGAPN in the over-expressing lines (Supplemental Figure 4). Also note that
only the full-length TgAPE appeared on the immunoblot probed with anti-FLAG
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(Supplemental Figure 4), confirming that the shorter form of TgAPE is missing a portion of
its N-terminal region.
3.6. Impaired response to DNA damage in TgAPN knockdown parasites
To determine if the predominant AP endonuclease is essential for Toxoplasma viability, we
first attempted knockouts in type I RH strain parasites using conventional recombination.
We did not obtain viable clones, possibly because the TgAPN gene is essential. To test this
idea, we created a conditional knockout for TgAPN in the TATi parasite background, which
expresses a transactivator protein that can be regulated by anhydrotetracycline (ATc) [28].
Ectopic HA-MYCAPNFLAG driven by the ATc-responsive SAG1 promoter was stably
expressed in TATi parasites. Next, the entire endogenous locus encoding TgAPN was
eliminated through homologous recombination. Over 130 clones were screened and a single
knockout was obtained and verified (data not shown). Unfortunately, addition of 1.0 μg/ml
ATc for 48 hrs did not significantly reduce the amount of ectopic TgAPN in the conditional
knockout clone (higher levels of ATc proved toxic). A modest slow growth phenotype
accompanied the conditional knockout treated with 1.0 μg/ml ATc (data not shown),
suggesting again that TgAPN may be important for Toxoplasma viability.
As an alternative approach, we engineered a “knock in” vector designed to place a fusion tag
onto the C-terminal end of TgAPN consisting of two HA epitopes and a destabilization
domain (2xHA-DD), which allows for regulated expression of the fusion protein through
addition of the stabilizing ligand Shield-1 [29]. RH strain parasites lacking Ku80 (Ku80-
KO), which display a significantly higher degree of homologous recombination [20,30],
were used to create Toxoplasma parasites expressing endogenous TgAPN fused to the
2xHA-DD tag (called TgAPN-2xHA-DD). We were able to obtain several clones tagged in
this fashion that behaved similarly. The ability to regulate levels of TgAPN-2xHA-DD
protein with Shield-1 was verified using IFA and immunoblotting (Fig. 5A and B).
TgAPN-2xHA-DD parasites cultured under normal conditions without Shield (TgAPN
knockdown) are viable, as reported for other species [12,31]. We then analyzed the ability of
purified, extracellular TgAPN knockdown parasites to recover from a direct 2 hr exposure to
25 μM MMS. Relative to the Ku80-KO parental line, the TgAPN knockdown parasites were
significantly impaired in recovering from the MMS insult (Fig. 6A). We also examined the
ability of intracellular TgAPN knockdown parasites to proliferate in the presence of MMS in
tissue culture. In these conditions, 25 μM MMS has no significant effect on parental or
TgAPN knockdown parasites (data not shown), possibly because the parasites are sheltered
by the host cells. But as shown in Fig. 6B, the parental Ku80-KO parasites show ~40%
reduction in growth in the presence of 100 μM MMS. In contrast, TgAPN knockdown
parasites show ~80% reduction in growth in the presence of 100 μM MMS (Fig. 6B).
Together these data further support that TgAPN plays a major role in the DNA damage
response in Toxoplasma.
Discussion
A number of protozoal species in phylum Apicomplexa have a tremendous impact on human
health and vitality of livestock. In addition to Toxoplasma, other important pathogens in this
phylum include Plasmodium, Cryptosporidium, and Eimeria. Plasmodium is the causative
agent of malaria and kills up to 2.7 million persons per year, over 75% of them children
[32]. Cryptosporidium causes acute diarrheal illness that can be extremely serious in the
young and immunocompromised [33]. Eimeria is a coccidian parasite of poultry, causing
losses in excess of $3 billion annually to US agribusiness [34]. A combination of too little
research and rapid spread of resistance to frontline drugs is grossly hindering our control of
these infectious diseases.
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The frontline treatment for Toxoplasma, pyrimethamine and sulfadiazine, is limiting for a
number of reasons. The treatment must be given in combination, the DHFR inhibitor
pyrimethamine causes bone marrow suppression, and numerous patients have or develop
allergies to sulfa drugs. The adverse effects are more pronounced in the
immunocompromised, the patient population that most commonly suffers from recurring
episodes of acute toxoplasmosis [35]. There is also a paucity of treatments that can be safely
administered during pregnancy to treat toxoplasmosis acquired in utero. In short, there is an
urgent need to develop novel therapies against Toxoplasma that are more selectively toxic.
Additionally, it is hoped that such novel therapies would also have utility against other
apicomplexan parasites, particularly if the therapies are targeted against crucial molecular
targets that are similar in protozoa.
Like other apicomplexans, Toxoplasma is an intracellular parasite exposed to an oxidative
burst generated by the host immune response in addition to ROS generated through its own
metabolism [15,36]. Consequently, intracellular organisms may incur extensive damage to
DNA that must be repaired for genomic stability and survival [16]. Especially relevant to
Toxoplasma are the generation of abasic sites in DNA, which result from removal of
oxidized or alkylated bases. These sites are repaired by AP endonucleases during BER.
Limited work has been performed to date to characterize AP endonucleases in protozoa. AP
endonucleases have been studied in kinetoplastid parasites Trypanosoma cruzi and
Leishmania major [37]. Over-expression of the L. major AP endonuclease (LMAP), which
is an APE1 (ExoIII) homologue, protects the protist from DNA damage [5]. The crystal
structure for LMAP has recently been solved, and it largely resembles other APE1
orthologues [38]. It has been reported that Plasmodium falciparum predominantly uses long-
patch BER as opposed to short-patch BER, which is the predominant pathway in most other
species including human, and biochemical activities for class II, Mg2+-dependent and
independent AP endonucleases have been described [23,39]. Our study confirms the
presence of two AP endonucleases in fellow apicomplexan Toxoplasma, the Mg2+-
dependent TgAPE and Mg2+-independent TgAPN.
TgAPE does not appear to be abundant in tachyzoites, but it may be upregulated during
another life cycle stage. It should be noted that recombinant TgAPE displays fast substrate
turnover rate (Fig. 1C), which may offset its low abundance in tachyzoites. The fast turnover
rate observed for TgAPE may result from fast product release. In human APE1, R177 has
been shown to slow product release potentially facilitating recruitment of β polymerase to
the site [7,9]. Thus, the R177A human APE1 enzyme actually has a faster turnover rate than
the wild-type enzyme. In TgAPE, the residue equivalent to R177 in TgAPE1 is A253, which
by analogy may also result in faster product release. It is also interesting that over-
expression of TgAPE failed to provide protection against MMS (Fig. 4). There are at least
two possible explanations for this result. It is possible that TgAPE requires additional factors
in vivo that are not present in stoichiometric amounts to over-expressed TgAPE. A second
possibility is that TgAPE has evolved to serve a different DNA repair related function in
Toxoplasma. Although TgAPE efficiently cleaves an oligonucleotide substrate including an
abasic site mimic, it lacks the residues found in other APE1 enzymes that confer specificity
for this substrate, namely W280 and F266. Substitution of residues equivalent to F266 and
W280 in the APE-like enzyme from the hyperthermophilic archaeon Archaeoglobus
fulgidus resulted in an increase in non-specific endonucleolytic activity and exonucleolytic
activity [40]. In contrast, all of the residues that confer specificity for abasic site specificity
are conserved in the TgAPN enzyme.
Another interesting finding from our studies is that TgAPE exists as two forms, the shorter
one being in the cytoplasm and possibly the apicoplast. The presence of truncated APE1 in
the cytoplasm is not without precedent; the distribution of human APE1 in the nucleus and
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cytosol is in a dynamic equilibrium and the nuclear transport of human APE1 requires its 20
N-terminal residues [41]. Localization of TgAPE to the apicoplast could be a significant
finding as this plastid-like organelle houses its own 35 kb genome that is essential for
Toxoplasma viability [42]. In addition to its endonuclease activities, human APE1 can
regulate transcription by virtue of its redox activity; the TgAPE homologue, however, has a
valine residue in the position equivalent to cysteine residue 65, which is essential for redox
activity in the human enzyme [43–45]. Further investigation into the precise role of TgAPE
in the parasite is an important future study.
Alteration of TgAPN levels alters susceptibility of the parasite to DNA damage, marking the
first demonstration that such enzymes may be attractive drug targets against intracellular
protozoan pathogens. A knockdown of TgAPN was viable, but significantly impaired in
recovering from DNA damage (Fig. 6). As in humans, the total knockout of the main AP
endonuclease is not viable and only cells with low levels of APE can escape death. This
appears to be similar to our findings that we have been unable to knockout or knockdown
TgAPN completely. Therefore, it would be of interest to determine if complete inhibition of
TgAPN by a small molecular inhibitor would be detrimental to parasite proliferation.
Humans do not possess APN1 homologues, and the TgAPN enzyme is structurally unrelated
to human APE1, making it likely that compounds will be identified that specifically inhibit
Toxoplasma BER without inhibiting its human counterpart allowing for a large therapeutic
index with predicted limited toxicity. These predictions must wait for the identification of
small molecule inhibitors, which is currently underway in our laboratories.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. TgAPE and TgAPN AP endonuclease assays
A and B. Reactions contained 1 mM DTT and 0.05 pmol HEX-THF oligonucleotide
substrate in a total volume of 10 μl and were incubated at 37 °C for 15 min. The reactions
were analyzed on a 20% denaturing polyacrylamide gel. The lower band on the gel is
cleaved AP oligo substrate, and its generation represents active AP endonuclease activity.
The upper band is uncleaved substrate. A. The AP activity of purified recombinant TgAPE
is dependent on Mg2+. Increasing amounts of TgAPE protein (ng) were incubated with AP
activity assay buffer for hAPE1 protein (50 mM Hepes, 50 mM KCl, 10 mM MgCl2, 1 μg/
ml BSA, 0.05% TritonX-100, pH 7.5), or APN buffer, which is identical but without MgCl2,
and includes 20 mM EDTA. B. Purified recombinant TgAPN is active in both buffers since
it does not require Mg2+. C and D. A fluorescent-based solution assay was used to
characterize the steady state kinetic properties of TgAPE (C) and TgAPN (D). Using
optimized concentrations of TgAPE (0.05 nM) and TgAPN (4 nM) and substrate
concentrations from 0 to 75 nM, Km values of 21.1 and 26.2 nM, respectively, were
determined. Vmax values for the two enzymes differ by a factor of 75, with TgAPE
exhibiting the more rapid rate of endonuclease activity.
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Figure 2. Characterization of Toxoplasma AP endonucleases
A. Western analysis with affinity-purified anti-TgAPE or anti-TgAPN, each used at a
1:10,000 dilution. The designated amount of Toxoplasma protein lysate is shown.
Recombinant (r) protein expressed and purified from E. coli was run as control, and suggests
anti-TgAPE binds its protein with greater affinity than anti-TgAPN, yet TgAPN is much
more readily detected in lysates derived from tachyzoites. B. IFA of intracellular parasites
probed with 1:1,000 dilution of anti-TgAPE (top panels, green) or 1:10,000 dilution anti-
TgAPN (lower panels, green). 4′,6-diamidino-2-phenylindole (DAPI) was used as a co-stain
to highlight the nuclear compartment (blue). hN= host cell nucleus. Arrowheads point to
parasite apicoplast organelle. C. Total AP endonuclease activity in wild-type Toxoplasma
lysate, performed in presence of 1.0 mM MgCl2. Lane 1, 10 nM recombinant human APE1
(PC, positive control); lane 2, DNA alone (NC, negative control); lanes 3–8, increasing
amounts of Toxoplasma lysate (100, 250, 500, 1000, 1500 and 3000 ng, respectively). The
columns on the graphs below each gel correspond to the percent activity of the sample
directly above and are representative of the average percent activity of two independent
assays. D. APN activity levels in parasite lysate, as determined by degree of cleaved
oligonucleotide. AP endonuclease assays were performed in the presence of 10 mM EDTA
to chelate Mg2+. Lane 1, 10 nM recombinant TgAPN (PC, positive control); lane 2, DNA
alone (NC, negative control); lanes 3–8, increasing amounts of Toxoplasma lysate (100, 250,
500, 1000, 1500 and 3000 ng, respectively).
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Figure 3. Localization of FLAG-tagged AP endonucleases
IFA was performed on intracellular parasites expressing FLAGAPE (top panels) or FLAGAPN
(bottom panels). Parasites were probed with anti-FLAG (1:5,000) and either anti-TgAPE
(1:1,000) or anti-TgAPN (1:10,000). DAPI was used as a co-stain to highlight the parasite
nucleus (blue).
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Figure 4. DNA damage recovery assays
Extracellular parasites (wild-type (WT), FLAGAPE and FLAGAPN) were subjected to DNA
damage induced by MMS or vehicle control (DMSO) for 2 hr and then allowed to infect
fresh HFF monolayers under normal culture conditions. A. Parasite growth was monitored
by PCR-based B1 assay following exposure to 400 μM MMS. B. Parasite growth was
measured using a plaque assay in either 400 or 800 μM MMS. C. Parasite doubling assays
were performed following exposure to 800 μM MMS. Error bars indicate the SD of the
mean. The times designated for the MMS treated samples are a reflection of the lag in
parasite proliferation due to recovery from the MMS treatment.
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Figure 5. Knockdown of TgAPN protein using ligand-controlled destabilization domain
A parasite clone was generated to express endogenous TgAPN fused to a tag containing two
HA epitopes and a destabilization domain (2xHA-DD). A. TgAPN-2xHA-DD is rapidly
degraded unless stabilized through the inclusion of 100 nM Shield-1 in the media. IFA of
TgAPN-2xHA-DD parasites grown with (+) or without (−) Shield, probed with anti-TgAPN
(1:10,000, green) or anti-HA (1:2,000, red). DAPI was used as a nuclear co-stain (blue). hN
= host cell nucleus. B. Western blot analysis of TgAPN-2xHA-DD parasites grown with (+)
or without (−) Shield, probed with anti-HA (1:3,000, left) or anti-TgAPN (1:10,000, right).
Ten μg of parasite lysate was used for the immunoblots. Tubulin was monitored as a loading
control.
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Figure 6. TgAPN knockdown parasites exhibit impaired response to DNA damage
A. Parental (Ku80-KO) and TgAPN-2xHA-DD parasites cultured without Shield (TgAPN
knockdown, KD) were purified and subjected to 25 μM MMS for 2 hrs prior to being placed
back in culture to infect fresh host cells. Growth was monitored at day 5 using the PCR-
based B1 assay (* denotes p=0.000463, student t-test). B. Parental (Ku80-KO) and
TgAPN-2xHA-DD parasites cultured without Shield were allowed to infect HFF
monolayers incubated in the presence of 100 μM MMS (white bars) or vehicle control
(black bars). Growth was monitored at day 7 using the B1 assay. Error bars indicate the SD
of the mean.
Onyango et al. Page 20
DNA Repair (Amst). Author manuscript; available in PMC 2012 May 5.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
